Etravirine-based antiretroviral therapy in HIV/hepatitis C virus coinfected advanced fibrosis patients receiving triple therapy against hepatitis C virus with telaprevir

AIDS. 2014 Oct 23;28(16):2487-9. doi: 10.1097/QAD.0000000000000425.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Adult
  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use*
  • Cohort Studies
  • Coinfection / drug therapy*
  • Drug-Related Side Effects and Adverse Reactions
  • Female
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Liver Cirrhosis / drug therapy*
  • Male
  • Middle Aged
  • Nitriles
  • Oligopeptides / adverse effects
  • Oligopeptides / therapeutic use*
  • Pyridazines / adverse effects
  • Pyridazines / therapeutic use*
  • Pyrimidines
  • Retrospective Studies
  • Spain
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Nitriles
  • Oligopeptides
  • Pyridazines
  • Pyrimidines
  • etravirine
  • telaprevir